Biosimilars in Cancer
- 1st Edition - December 1, 2026
- Latest edition
- Editors: Ranjita Shegokar, Yashwant Pathak
- Language: English
Biosimilars in Cancer is a comprehensive resource addressing the role of biosimilars in treating various cancer types. This book offers a succinct yet thorough overview of curren… Read more
Data Mining & ML
Unlock the cutting edge
Up to 20% on trusted resources. Build expertise with data mining, ML methods.
Description
Description
Key features
Key features
- Offers detailed information on 21 different cancer types, ensuring a broad understanding of biosimilar applications in oncology
- Presents up-to-date insights into the rapidly evolving field of cancer treatment, helping researchers and clinicians stay ahead
- Integrates fundamental facts with practical and clinically relevant data, making it a valuable resource for academic and clinical purposes
Readership
Readership
Table of contents
Table of contents
2. Pancreatic Cancer: Biosimilars in Cancer Research
3. Heart Cancer: Biosimilars in Cancer Research
4. Bone Cancer: Biosimilars in Cancer Research
5. Spleen Cancer: Biosimilars in Cancer Research
6. ENT Cancer: Biosimilars in Cancer Research
7. Brain/CNS Cancer: Biosimilars in Cancer Research
8. Skin Cancer: Biosimilars in Cancer Research
9. Lung Cancer: Biosimilars in Cancer Research
10. Thorax Cancer: Biosimilars in Cancer Research
11. Thyroid Cancer: Biosimilars in Cancer Research
12. Kidney-Adrenal Cancer: Biosimilars in Cancer Research
13. Urinary Tract Cancer: Biosimilars in Cancer Research
14. Breast Cancer: Biosimilars in Cancer Research
15. Colorectal Cancer: Biosimilars in Cancer Research
16. Blood Cancer: Biosimilars in Cancer Research
17. Prostate Cancer: Biosimilars in Cancer Research
18. Ovarian Cancer: Biosimilars in Cancer Research
19. Stomach and Intestinal Cancer: Biosimilars in Cancer Research
20. Pleura and Peritoneum Cancer: Biosimilars in Cancer Research
21. Oral Cancer: Biosimilars in Cancer Research
Product details
Product details
- Edition: 1
- Latest edition
- Published: December 1, 2026
- Language: English
About the editors
About the editors
RS
Ranjita Shegokar
Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)
YP